Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Wick
Michael Weller

Showing results (1-10 of 1,397) with videos related to

Pageof 140
Sort By:
Current Opinion in Neurology|September 23, 2009
Classification and management of anaplastic gliomasWolfgang Wick, Michael Weller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
How lymphotoxic is dose-intensified temozolomide? The glioblastoma experienceWolfgang Wick, Michael Weller
Neuro-Oncology|March 25, 2011
Are we ready to demystify age in glioblastoma? Or does older age matter in glioblastoma?Michael Weller, Wolfgang Wick
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Adjuvant therapyWolfgang Wick, Michael Weller
Neuro-Oncology|May 12, 2011
Trabedersen to target transforming growth factor-beta: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142)Wolfgang Wick, Michael Weller
Der Nervenarzt|May 20, 2015
[Neuro-oncology]Wolfgang Wick, Michael Weller
Nature Reviews. Neurology|January 15, 2014
Neuro-oncology in 2013: improving outcome in newly diagnosed malignant gliomaMichael Weller, Wolfgang Wick
Current Opinion in Neurology|October 22, 2010
Steroids in neurooncology: actions, indications, side-effectsPatrick Roth, Wolfgang Wick, Michael Weller
CNS Oncology|July 24, 2014
Shaping the glioma immune microenvironment through tryptophan metabolismMichael Platten, Michael Weller, Wolfgang Wick
Critical Reviews in Oncology/Hematology|February 3, 2016
Therapeutic options in recurrent glioblastoma--An updateKatharina Seystahl, Wolfgang Wick, Michael Weller
Pageof 140

Showing results (1-10 of 1,397) with videos related to

Sort By:
Pageof 140
Current Opinion in Neurology|September 23, 2009
Classification and management of anaplastic gliomasWolfgang Wick, Michael Weller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
How lymphotoxic is dose-intensified temozolomide? The glioblastoma experienceWolfgang Wick, Michael Weller
Neuro-Oncology|March 25, 2011
Are we ready to demystify age in glioblastoma? Or does older age matter in glioblastoma?Michael Weller, Wolfgang Wick
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Adjuvant therapyWolfgang Wick, Michael Weller
Neuro-Oncology|May 12, 2011
Trabedersen to target transforming growth factor-beta: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142)Wolfgang Wick, Michael Weller
Der Nervenarzt|May 20, 2015
[Neuro-oncology]Wolfgang Wick, Michael Weller
Nature Reviews. Neurology|January 15, 2014
Neuro-oncology in 2013: improving outcome in newly diagnosed malignant gliomaMichael Weller, Wolfgang Wick
Current Opinion in Neurology|October 22, 2010
Steroids in neurooncology: actions, indications, side-effectsPatrick Roth, Wolfgang Wick, Michael Weller
CNS Oncology|July 24, 2014
Shaping the glioma immune microenvironment through tryptophan metabolismMichael Platten, Michael Weller, Wolfgang Wick
Critical Reviews in Oncology/Hematology|February 3, 2016
Therapeutic options in recurrent glioblastoma--An updateKatharina Seystahl, Wolfgang Wick, Michael Weller
Pageof 140